STBL Sell-Off Sparks Insider Trading Allegations and Market Panic
STBL’s massive price drop and alleged insider sell-offs have shaken investor confidence. While the team vows transparency and recovery efforts, the market remains split between hopes of a rebound and fears of deeper distrust.
STBL has lost 80% of its value from its peak, plunging the token into a significant decline. Additionally, the token is now mired in controversy as the founding team faces accusations of selling off millions of dollars’ worth of tokens.
Meanwhile, the project is moving forward with plans to mint 100 million USST and launch a repurchase program by the end of October. This development has divided the market between hopes of recovery and fears of collapsing trust.
Who Sold — and Why Did the Market React So Sharply?
Within just a month of its launch, STBL, the token of the stablecoin protocol of the same name, has plunged more than 80% in value. Data from BeInCrypto shows that STBL hit an all-time high around $0.60, then dropped to a low of about $0.0797 before recovering slightly to $0.11478. At this price, STBL’s market cap hovers near $58 million.
STBL price performance. Source:
STBL
According to Bubblemaps, on-chain data revealed that at least five large addresses sold all of their STBL holdings, pocketing roughly $17 million in profits. Notably, these same five addresses were linked to early STBL trading activity in September — when they collectively earned over $10 million during the token’s launch phase.
STBL sell trades by 5 major traders. Source:
Bubblemaps
This pattern has sparked speculation within the crypto community about potential insider trading or coordinated sell-offs. Some X users described these accounts as “snipers,” implying algorithmic or insider-led operations rather than normal market participants.
“I don’t like these snipers; they could be insiders or maybe not, but they’ve dragged my $STBL portfolio deep underwater. Anyway, luckily, the bastard is out, and I still have enough stablecoin outside to buy some more at the current bottom,” one trader wrote.
While some observers labeled the sellers as casual traders, STBL’s CEO Avtar Sehra pushed back, asserting these were “orchestrated and professional accounts,” citing the Bubblemaps findings.
STBL’s team has publicly denied any internal involvement in the sell-off. In a statement, they emphasized that treasury operations remain transparent and that no team allocations or vesting schedules have changed:
“We’re focused on building the protocol and adoption with the community. Allocations/vesting are unchanged. Furthermore, any tokens vesting this quarter won’t be minted and will not enter circulation.” STBL shared.
Despite the turmoil, STBL announced its intention to mint 100 million USST in Q4. The move raised concerns that an increased token supply could add further selling pressure, especially amid shaken investor confidence. Previously, as BeInCrypto reported, the STBL team also said that they will open a USST repurchase and staking program at the end of October, aiming to restore liquidity and stabilize the token value.
Technical Analysis: Accumulation Zone or Dead-Cat Bounce?
According to crypto analyst Michaël van de Poppe, the current price action may represent a key accumulation phase, as STBL forms a technical bottom near $0.09–$0.10. He suggests that if sentiment improves, the token could rebound toward the $0.17–$0.20 resistance range — previous support levels now flipped into resistance.
STBL price analysis. Source:
Michaël van de Poppe
However, Michaël van de Poppe also cautioned that a sustained uptrend can only occur if market volume recovers and fresh capital returns to the project. Until then, STBL’s fate remains uncertain — teetering between a cautious rebound narrative and the shadow of a credibility crisis.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
AI Sell-off Hits Anthropic IPO, Potential Valuation Expected to Drop to $1.2–1.3 Trillion
The valuation range discussed by potential investors has been lowered from the previous high of $2 trillion to between $1.2 trillion and $1.3 trillion, and some strategists have even suggested going below $1 trillion to ensure safety. In the face of significant market volatility and financial concerns such as quarterly losses, Anthropic is facing tough decisions, including a discounted valuation, reducing the size of the offering, or postponing the listing.

Moderna Q3 revenue up 29% year-on-year, far exceeding expectations, raises full-year revenue growth guidance to 15%-25% | Earnings Report Insight
Moderna's Q3 revenue increased by 29% year-on-year to $1.31 billion, with profits significantly exceeding expectations. The company raised its 2026 revenue growth guidance to 15%-25%. The ramp-up of next-generation COVID-19 and flu vaccines, along with international market expansion, has driven performance improvement. Phase III data for the personalized cancer vaccine has also shown positive progress. The company is simultaneously advancing cost reduction and pipeline R&D, with year-end cash expectations significantly raised.
Eli Lilly (LLY.US) "lowers its stance" and joins forces with former rival Hims (HIMS.US) to compete for the self-pay weight loss drug market
Eli Lilly is collaborating with Hims & Hers Health, leveraging the telehealth company’s large customer base to expand access to its blockbuster weight loss drugs and boost sales of medications, including its new oral weight loss drug Foundayo.

